Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Broxine Tablet may be taken with or without food, but it is better to take it at a fixed time. Take it with food if stomach upset occurs.
Broxine Tablet is a combination of four medicines: Bromhexine, Paracetamol, Chlorpheniramine and Phenylpropanolamine which relieve common cold symptoms. Bromhexine is a mucolytic which thins and loosens mucus (phlegm), making it easier to cough out. Paracetamol is an analgesic (pain reliever) and antipyretic (fever reducer). It blocks the release of certain chemical messengers in the brain that cause pain and fever. Chlorpheniramine is an antiallergic which relieves allergy symptoms like runny nose, watery eyes and sneezing. Phenylpropanolamine is a sympathomimetic agonist. It narrows blood vessels in the nose to relieve congestion.
Taking phenylpropanolamine with alcohol can increase the risk of cardiovascular side effects such as increased heart rate, chest pain, or blood pressure changes.
WEIGH RISKS VS BENEFITS
Broxine Tablet may be unsafe to use during pregnancy. Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
No information is available on the use of Broxine Tablet during lactation. Please consult your doctor.
Broxine Tablet may make you feel dizzy, sleepy, tired, or decrease alertness. If this happens, do not drive.
Broxine Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Broxine Tablet may not be needed in these patients. Please consult your doctor. Use of Broxine Tablet may cause excessive sleepiness in patients with end stage kidney disease.
Broxine Tablet should be used with caution in patients with liver disease. Dose adjustment of Broxine Tablet may be needed. Please consult your doctor. However, the use of Broxine Tablet is not recommended in patients with severe liver disease and active liver disease.